UBS Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.3K Sell
3,879
-235,141
-98% -$3.89M ﹤0.01% 7164
2025
Q4
$3.15M Buy
239,020
+154,673
+183% +$1.82M ﹤0.01% 4511
2025
Q3
$605K Buy
84,347
+3,997
+5% +$208K ﹤0.01% 5947
2025
Q2
$3.79M Sell
80,350
-40,419
-33% -$1.65M ﹤0.01% 4160
2025
Q1
$4.72M Buy
120,769
+92,851
+333% +$4M ﹤0.01% 3837
2024
Q4
$1.51M Buy
27,918
+21,578
+340% +$1.1M ﹤0.01% 4977
2024
Q3
$320K Buy
6,340
+3,073
+94% +$144K ﹤0.01% 5527
2024
Q2
$144K Sell
3,267
-11,485
-78% -$486K ﹤0.01% 5901
2024
Q1
$741K Buy
14,752
+14,111
+2,201% +$765K ﹤0.01% 4859
2023
Q4
$38.7K Sell
641
-484
-43% -$24.9K ﹤0.01% 6692
2023
Q3
$64.1K Buy
+1,125
New +$62.1K ﹤0.01% 6124
2023
Q2
Sell
-7,960
Closed -$170K 9372
2023
Q1
$170K Sell
7,960
-65,428
-89% -$1.1M ﹤0.01% 5517
2022
Q4
$771K Sell
73,388
-2,276
-3% -$20.2K ﹤0.01% 4310
2022
Q3
$587K Buy
75,664
+2,004
+3% +$14.2K ﹤0.01% 4187
2022
Q2
$387K Buy
73,660
+71,968
+4,253% +$452K ﹤0.01% 4451
2022
Q1
$19K Buy
+1,692
New +$16.8K ﹤0.01% 7514
2021
Q3
Sell
-374
Closed -$4K 9862
2021
Q2
$4K Buy
+374
New +$3.8K ﹤0.01% 8680

Other funds holding MLTX